ARCHIVES

Emory Executive Objects to Report On Merit review

This article is from The Cancer Letter archive.

Vol. 03 No. 29 | July 22, 1977

Download PDF Visit The Full Archive

Related Articles

Avastin-Zybrestat Combination Increases Progression-Free Survival in Phase II Trial

March 28, 2014

NCI Officials Open To Fine-Tuning Group Budgets As Advocates Chip Away At NCTN’s Façade

May 2, 2014

Insurance Co. Official Says Cancer Centers, Insurers Are “Allies”

June 2, 1995

New CIDAC RFP Limits Recompetition To Small Business Firms

January 6, 1984

Carcinogenesis Testing To Stay In NCI, But Control Will Go To New Group Headed By Rall

September 15, 1978

Progress Reported On Zinder Recommendations for Virus Program

July 4, 1975